Sp216
PANEL DISCUSSION
Date
May 6, 2023
Explore related products in the following collection:
Tracks
Related Products
EFFECTS OF THE FGF-19 ANALOG ALDAFERMIN ON BILE ACID SYNTHESIS AND EXCRETION AND BOWEL FUNCTION IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME AND BILE ACID MALABSORPTION: A RANDOMIZED PLACEBO-CONTROL TRIAL
Ageing seems to have a beneficial effect on irritable bowel syndrome (IBS) (Sperber et al. Gastroenterology 2021), and the odds of developing IBS are lower when age is above 50 years (Lovell & Ford CGH 2012). Older age may also affect symptom reporting and quality of life…
AGA Frances and Don W. Powell, MD, Lecture: New Treatments for Bile Acid Diarrhea
Bile acid diarrhea is a poorly recognized cause of bowel symptoms. The pathophysiology is varied and includes bile acid overproduction and malabsorption. Recent studies have provided new evidence of targets for therapy and will be reviewed in this session…
MACHINE-LEARNING DRIVEN, FULL PHENOTYPE MODEL AND SURROGATE POLYGENIC RISK SCORE MODEL FOR APPETITE PREDICT RESPONSE TO GLP-1 RECEPTOR AGONIST IN PATIENTS WITH OBESITY
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
INCREASED NUMBERS OF SINGLE NUCLEOTIDE VARIANTS IN GENES RELATED TO BILE ACID KINETICS ARE ASSOCIATED WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A WHOLE EXOME SEQUENCING STUDY OF 526 PATIENTS AND 2950 CONTROLS
BACKGROUND: Irritable bowel syndrome (IBS) is a common disorder with complex pathophysiological mechanisms. Prior studies suggest that 25-50% of patients with diarrhea-predominant IBS (IBS-D) have evidence of bile acid (BA) diarrhea (BAD)…